In contrast, synthetic inhibitors such as MK-0736 and MK-0916 have demonstrated therapeutic efficacy in overweight patients
Increasing dietary protein and high protein meals have both been shown to elevate levels of glucagon-like peptide 1 (GLP-1), cholecystokinin (CKK), peptide-YY (PYY) and other hormones that are associated with feelings of fullness
As observed by Junita et al
For example, TPD uses an event-driven, catalytic mechanism, allowing the compounds to bind anywhere on their target protein, bind less potently than traditional inhibitors, and be used at sub-stoichiometric levels
PSD-95, the increased expression of which at synapses is critical for persistent spine enlargement (Meyer et al., 2014), may also act as a positive PRP
In any case, most side effects were tolerable and tended to get better with time